MedPath

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Phase 4
Conditions
Patients With T1-4 Advanced Prostate Cancer
Registration Number
NCT00293670
Lead Sponsor
Tampere University
Brief Summary

To compare intermittent androgen deprivation (LHRHa treatment) with continuous androgen deprivation (LHRHa treatment or orchidectomy)

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
573
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time To Progression (TTP)
Secondary Outcome Measures
NameTimeMethod
Overall and prostate cancer-specific survival, time to treatment failure, quality of life

Trial Locations

Locations (1)

TUCH (Tampere University Central Hospital)

🇫🇮

Tampere, Finland

© Copyright 2025. All Rights Reserved by MedPath